Pearls & Oy-sters: The medial longitudinal fasciculus in ocular motor physiology
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To review the role played by the medial longitudinal fasciculus (MLF) in ocular motor physiology and to characterize a number of syndromes that result from lesions in this eloquent brainstem tract system.
Background: The MLF is responsible for transmitting information that is crucial for the coordination and synchronization of all major classes of eye movements. A number of disease processes can produce lesions within this small yet highly strategic white matter pathway resulting in a myriad of neuro-ophthalmologic signs and symptoms.
Methods: We carefully reviewed both the literature and our collective experiences to systematically consider the neuroanatomy and physiology of the MLF and the pathophysiologic mechanisms that underlie syndromes deriving from lesions in this pathway.
Results: The MLF is an important structure and is composed of numerous projection systems involved in the regulation of eye movements. Pathology at this location can produce a constellation of abnormalities, many of which can be identified upon careful bedside neurologic examination.
Conclusion: This review of the medial longitudinal fasciculus and its constituent pathways is germane to understanding a number of important principles in neuro-ophthalmology.
GLOSSARY: FEF = frontal eye field; FPA = first-pass amplitude; INC = interstitial nucleus of Cajal; INO = internuclear ophthalmoparesis; MLF = medial longitudinal fasciculus; MS = multiple sclerosis; NPH = nucleus prepositus hypoglossi; NRTP = nucleus reticularis tegmenti pontis; OD = right eye; OS = left eye; OTR = ocular tilt reaction; PPRF = paramedian pontine reticular formation; PSP = progressive supranuclear palsy; r-VOR = rotational vestibular ocular reflex; riMLF = rostral interstitial nucleus of the MLF; SC = superior colliculus; SVN = superior vestibular nucleus; VDI = versional disconjugacy index; VLVN = ventral lateral vestibular nucleus.
Footnotes
-
elliot.frohman{at}utsouthwestern.edu
Supported by the National Multiple Sclerosis Society (Lone Star Chapter), the “Once Upon A Time,” the Cain/Denius Comprehensive Center for Mobility Research, the Irene Wadel and Robert Atha fund, the Kenney Marie Dixon Pickens fund, and the Jean Ann and Steve Brock Fund for Medical Sciences.
Disclosure: Teresa Frohman has no conflicts to declare. Steven Galetta has received lecture fees from Biogen Idec. Dr. Fox has received grant or research support from Biogen Idec, Genentech, Merck, National Institutes of Health, and National MS Society. Bob Fox has served as a consultant for Biogen Idec, Genentech, Merck, Questcor, and Teva Neuroscience. David Solomon has no conflicts to declare. Dominik Straumann has no conflicts to declare. Massimo Filippi has received grants/contracts and honoraria/consultation fees from TEVA Neuroscience, Dompè Biogen, Bayer-Shering, and Merck-Serono. David Zee has no conflicts to declare. Elliot Frohman has received lecture fees from Biogen Idec, TEVA, and Serono and consulting fees from Biogen Idec.
Series editor: Mitchell S.V. Elkind MD, MS, Section Editor
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- MLF CIRCUITRY OF SACCADIC EYE MOVEMENTS
- VESTIBULAR COMPONENTS OF THE MLF
- INTERNUCLEAR OPHTHALMOPARESIS
- NEUROPHYSIOLOGY OF INO
- INO+ SYNDROMES
- ABNORMAL VERTICAL EYE MOVEMENTS WITH MLF LESIONS
- CLINICAL MANIFESTATIONS OF INO
- RADIOGRAPHIC IDENTIFICATION OF MLF LESIONS
- DISEASES TARGETING THE MLF
- PROGNOSIS AND TREATMENT
- RECENT ADVANCES AND FUTURE DIRECTIONS
- ACKNOWLEDGMENT
- Footnotes
- REFERENCES
- Figures & Data
- Info & Disclosures
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Medical Hypothesis
A hypothetical scheme for the brainstem control of vertical gazeRoongroj Bhidayasiri, Gordon T. Plant, R. John Leigh et al.Neurology, May 23, 2000 -
Article
Abnormalities of torsional fast phase eye movements in unilateral rostral midbrain diseaseP. Riordan-Eva, M. Faldon, J. A. Buttner-Ennever et al.Neurology, July 01, 1996 -
Article
Impaired vestibular responses in internuclear ophthalmoplegiaAssociation and dissociationSeo-Young Choi, Hyo-Jung Kim, Ji-Soo Kim et al.Neurology, November 15, 2017 -
Clinical/Scientific Notes
Jerky seesaw nystagmus in isolated internuclear ophthalmoplegia from focal pontine lesionK. Oh, J. H. Chang, K. -W. Park et al.Neurology, April 11, 2005